On the recordMay 19, 2014
the purpose of the breakthrough therapy designation was to, as you say, Mr. Pallone, too, advance and give the flexibility for FDA to respond to the current state of science
Source
congress.govEditor's note · Context
Pallone discusses the FDA's flexibility in drug approval processes.
Share
More from Frank Pallone
Jun 12, 2026
Amtrak must take prudent, extraordinary measures to reduce the likelihood of disruptions and maximize its ability to restore service quickly if an issue occurs.
Jul 16, 2026
“It’s time to finally end the process of springing forward and falling back,”
Jul 17, 2026
The most common cancer in the United States is skin cancer, with at least one in five Americans developing it during their lifetime.
Jun 2, 2026
Today is the first day of hurricane season, and FEMA still hasn't answered basic questions about whether it's ready.
Other voices in this conversation
